Skip to Main Content

Paper Details

Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply.
JAMA Cardiol
0
2017
Author NameAffiliation
Alfred E BuxtonBeth Israel Deaconess Medical Center, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2